| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.13▼ | 4.14▼ | 4.18▼ | 4.67▼ | 4.38▼ |
| MA10 | 4.13▼ | 4.22▼ | 4.30▼ | 4.86▼ | 4.14▼ |
| MA20 | 4.16▼ | 4.32▼ | 4.42▼ | 4.44▼ | 5.15▼ |
| MA50 | 4.28▼ | 4.56▼ | 5.04▼ | 4.12▼ | 10.20▼ |
| MA100 | 4.38▼ | 5.03▼ | 4.69▼ | 5.77▼ | 40.17▼ |
| MA200 | 4.66▼ | 4.55▼ | 4.19▼ | 8.59▼ | 72.53▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | -0.007▼ | -0.010▼ | -0.033▼ | 0.607▲ |
| RSI | 36.859▼ | 29.968▼ | 33.842▼ | 45.745▼ | 37.476▼ |
| STOCH | 32.128 | 4.736▼ | 13.509▼ | 17.406▼ | 32.938 |
| WILL %R | -87.500▼ | -97.826▼ | -90.000▼ | -94.234▼ | -83.871▼ |
| CCI | -117.949▼ | -93.364 | -129.630▼ | -65.670 | 4.890 |
|
Wednesday, April 30, 2025 04:30 AM
Phase 3 clinical data shows potential predictive biomarkers for treatment response, first identified in Phase 2 studyBiomarkers could be utilized to predict and provide better patient outcomes, ...
|
|
Tuesday, April 29, 2025 03:10 PM
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXZ) , a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, announced the pricing of an underwritten public ...
|
|
Tuesday, April 29, 2025 07:37 AM
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXZ) , a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, announced the pricing of an underwritten public ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 4.40 | 4.4985 | 4.09 | 4.10 | 401,890 |
| 30/04/25 | 4.50 | 4.56 | 4.0406 | 4.46 | 453,579 |
| 29/04/25 | 4.92 | 4.955 | 4.53 | 4.59 | 675,878 |
| 28/04/25 | 5.01 | 5.27 | 4.71 | 5.00 | 1,306,371 |
| 25/04/25 | 4.75 | 5.38 | 4.60 | 5.20 | 5,707,280 |
| 24/04/25 | 9.35 | 9.82 | 6.03 | 6.03 | 40,125,671 |
| 23/04/25 | 5.03 | 5.75 | 4.70 | 5.43 | 509,238 |
| 22/04/25 | 4.15 | 5.46 | 4.15 | 5.35 | 606,972 |
| 21/04/25 | 4.22 | 4.35 | 3.99 | 4.19 | 211,284 |
| 17/04/25 | 4.03 | 4.63 | 3.93 | 4.29 | 502,873 |
|
|
||||
|
|
||||
|
|